Showing posts with label medicines. Show all posts
Showing posts with label medicines. Show all posts

Friday, 4 December 2020

Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK

 The UK has become the first country in the world to approve the Pfizer/BioNTech coronavirus vaccine, paving the way for mass vaccination.

Britain's medicines regulator, the MHRA, says the jab, which offers up to 95% protection against Covid-19 illness, is safe to be rolled out.


The first doses are already on their way to the UK, with 800,000 due in the coming days, Pfizer said.


Health Secretary Matt Hancock said the NHS will contact people about jabs.


Getty Images


Elderly people in care homes and care home staff have been placed top of the priority list, followed by over-80s and health and care staff.


But because hospitals already have the facilities to store the vaccine at -70C, as required, the very first vaccinations are likely to take place there - for care home staff, NHS staff and patients - so none of the vaccine is wasted.


A further 648 deaths within 28 days of a positive Covid-19 test were recorded in the UK on Wednesday, with another 16,170 cases reported.


Prime Minister Boris Johnson urged the public not to get "carried away with over optimism or falling into the naive belief that our struggle is over".


He told a Downing Street news conference that, while the "searchlights of science" had created a working vaccine, significant logistical challenges remained.


The Pfizer/BioNTech jab is the fastest vaccine to go from concept to reality, taking only 10 months to follow the same steps that normally span 10 years.


The UK has already ordered 40 million doses of the jab - enough to vaccinate 20 million people.


The doses will be rolled out as quickly as they can be made by Pfizer in Belgium, Mr Hancock said, with the first load next week and then "several millions" throughout December.


Scottish First Minister Nicola Sturgeon said the first people in Scotland will be immunised on Tuesday.


Welsh Health and Social Care Minister Vaughan Gething said the rollout of the Pfizer jab to care homes would be particularly difficult because of how it needs to be stored.


Mr Gething said that it was not possible to transport the Pfizer vaccine to more than 1,000 care homes across Wales.


The bulk of the rollout across the UK will be next year, Mr Hancock said, adding: "2020 has been just awful and 2021 is going to be better."


While Mr Hancock said that the government does not yet know how many people need to be vaccinated before restrictions can start being lifted, he added: "I'm confident now, with the news today, that from spring, from Easter onwards, things are going to be better. And we're going to have a summer next year that everybody can enjoy."


Mr Johnson added: "It's the protection of vaccines that will ultimately allow us to reclaim our lives and get the economy moving again."


Downing Street press secretary Allegra Stratton said Mr Johnson would not rule out receiving the vaccine jab live on television, though she said he would not want to take a jab meant for someone more vulnerable.


The free vaccine will not be compulsory and there will be three ways of vaccinating people across the UK:

  • Hospitals
  • Vaccination centres "a bit like the Nightingales project and including some of the Nightingales", said Mr Hancock
  • In the community, with GPs and pharmacists

Around 50 hospitals are on stand-by and vaccination centres - in venues such as conference centres or sports stadiums - are being set up now.


It is thought the vaccination network could start delivering more than one million doses a week once enough doses are available.


NHS England chief executive Sir Simon Stevens said the health service was preparing for "the largest-scale vaccination campaign in our country's history".


But experts said people still need to remain vigilant and follow rules to stop the virus spreading - including with social distancing, face masks and self-isolation.


"We can't lower our guard yet," said the government's chief medical adviser Prof Chris Whitty.


The order in which people will get the jab is recommended by the Joint Committee on Vaccinations and Immunisations and decided by the government.


Mass immunisation of everyone over 50, as well as younger people with pre-existing health conditions, can happen as more stocks become available in 2021.


Pfizer confirmed that the first stocks of the vaccine will be for the NHS, which will give them out for free based on clinical need. People in the UK will not be able to bypass this and buy the vaccine privately to jump the queue.


The vaccine is given as two injections, 21 days apart, with the second dose being a booster. Immunity begins to kick in after the first dose but reaches its full effect seven days after the second dose.


Most of the side effects are very mild, similar to the side effects after any other vaccine and usually last for a day or so, said Prof Sir Munir Pirmohamed, the chairman of the Commission on Human Medicine expert working group.


The vaccine was 95% effective for all groups in the trials, including elderly people, he said.


The head of the MHRA, Dr June Raine, said that - despite the speed of approval - no corners have been cut.


Batches of the vaccine will be tested in labs "so that every single vaccine that goes out meets the same high standards of safety", she said.


Giving the analogy of climbing a mountain, she said: "If you're climbing a mountain, you prepare and prepare. We started that in June. By the time the interim results became available on 10 November we were at base camp.


"And then when we got the final analysis we were ready for that last sprint that takes us to today."


The Pfizer/BioNTech was the first vaccine to publish positive early results from final stages of testing.


It is a new type called an mRNA vaccine that uses a tiny fragment of genetic code from the pandemic virus to teach the body how to fight Covid-19 and build immunity.


An mRNA vaccine has never been approved for use in humans before, although people have received them in clinical trials.


Because the vaccine must be stored at around -70C, it will be transported in special boxes of up to 5,000 doses, packed in dry ice.


Once delivered, it can be kept for up to five days in a fridge. And once out of the fridge it needs to be used within six hours.




Other coronavirus vaccines are also being developed:

  • One from Moderna uses the same mRNA approach as the Pfizer vaccine and offers similar protection - the UK has pre-ordered seven million doses that could be ready by the spring
  • The UK has ordered 100 million doses of a different type of Covid vaccine from Oxford University and AstraZeneca
  • Russia has been using another vaccine, called Sputnik, and the Chinese military has approved another one made by CanSino Biologics.

The World Health Organization's Dr David Nabarro said the Pfizer vaccine would not replace the other measures "for a number of months, even a year, so we'll have to keep doing physical distancing, mask wearing, hygiene and isolating ourselves when we're sick".




He told BBC Radio 4's World at One programme "the vaccine will only start to dent the size of the pandemic somewhat later in the year".


Analysis by Nick Triggle, Health correspondent

There is a clear priority list for who gets the vaccine first - and care home residents and staff are top of it.


But operational complexities mean the reality will be somewhat different.


When the vaccines arrives, it will be sent straight to major hospitals who have the ultra-cold facilities to store it.


From there it can be moved just once - and when it is, it must be kept in batches of 1,000.


That means sending it out to care homes, where there may be only a few dozen residents in some places, would lead to a huge amount of vaccine being wasted.


Because of that, the NHS, which is in charge of distributing the vaccine, will run clinics from hospitals at first.


This will allow NHS and care home staff to get immunised first as well as, perhaps, some of the older age groups who come into hospital.


It looks like it will not be until much more of the Pfizer vaccine is available or the Oxford University one, which is easier to distribute, is approved that care home residents will be able to get it.


Analysis by  Hugh Pym, Health editor

The pace has been breathtaking.


From an unknown virus at the start of the year to a vaccine approved by the regulator and ready to use in early December is an unprecedented timescale.


At the Downing Street briefing, the MHRA's chief executive said it was like climbing Everest, with preparations starting in June and a team working "night and day" assessing early data and reaching "base camp" by early November when Pfizer/BioNtech published the trial results.


At the same time, the MHRA was adamant that the process had been robust with safety considerations paramount. A rapid emergency approval process was used by the UK regulator.


The European Medicines Agency is taking longer to reach a view and there has been some sniping from European politicians arguing their processes are more reliable and authoritative.


But the MHRA is an internationally respected independent watchdog and for now those about to receive the first jabs will rely on its ruling.


(Source: BBC)

Wednesday, 20 May 2020

Coronavirus: Trump says he is taking unproven drug hydroxychloroquine

US President Donald Trump has said he is taking hydroxychloroquine to ward off coronavirus, despite public health officials warning it may be unsafe.

Speaking at the White House, he told reporters he started taking the malaria and lupus medication recently.

"I'm taking it for about a week and a half now and I'm still here, I'm still here," was his surprise announcement.

There is no evidence hydroxychloroquine can fight coronavirus, and regulators warn the drug may cause heart problems.

What did Trump say?
The 73-year-old president was hosting a meeting devoted to the struggling restaurant industry on Monday, when he caught reporters unawares by revealing he was taking the drug.

"You'd be surprised at how many people are taking it, especially the frontline workers before you catch it, the frontline workers, many, many are taking it," he told reporters. "I happen to be taking it."

Asked what was his evidence of hydroxychloroquine's positive benefits, Mr Trump said: "Here's my evidence: I get a lot of positive calls about it."

He added: "I've heard a lot of good stories [about hydroxychloroquine] and if it's not good, I'll tell you right I'm not going to get hurt by it."

Though some people in the White House have tested positive for coronavirus, the president said again on Monday he had "zero symptoms" and was being tested frequently.

He added that he had been taking a daily zinc supplement and received a single dose of azithromycin, an antibiotic meant to prevent infection.

When asked whether the White House physician had recommended he start taking the disputed remedy, Mr Trump said he himself had requested it.

Dr Sean Conley, physician to the president, said in a statement issued through the White House later on Monday that Mr Trump was in "very good health" and "symptom-free".

The US Navy officer added: "After numerous discussions he and I had regarding the evidence for and against the use of hydroxychloroquine, we concluded the potential benefit from treatment outweighed the relative risks."


What have US health officials said?
The US Food and Drug Administration (FDA) last month issued an advisory saying that hydroxychloroquine has "not been shown to be safe and effective".

It cited reports that the drug can cause serious heart rhythm problems in Covid-19 patients.

The FDA warned against use of the medication outside hospitals, where the agency has granted temporary authorisation for its use in some cases. Clinical trials of the drug are also under way.

The Centers for Disease Control (CDC) says there are no approved drugs or therapeutics to prevent or treat Covid-19, which is confirmed to have infected more than 1.5 million people in the US, killing more than 90,000 patients.

What else did Trump say?
Dismissing reports of severe side effects from hydroxychloroquine, the president said: "All I can tell you is, so far I seem to be OK."

He said the "only negative" he had heard was from a "very unscientific report" conducted by "people that aren't big Trump fans".

Mr Trump was apparently referring to a preliminary study from April of Covid-19 patients in US government-run hospitals for military veterans that suggested hydroxychloroquine had no benefit and may have even caused a greater rate of deaths.

"I get a lot of tremendously positive news on the hydroxy," the president told reporters, adding: "What do you have to lose?"

According to doctors, the drug has the potential to cause symptoms including heart failure, suicidal thoughts and signs of liver disease.

What's the reaction?
Mr Trump's most powerful elected antagonist, the Democratic Speaker of the US House of Representatives, Nancy Pelosi, could not resist taking a dig at his age and weight when asked on CNN about him taking the malaria medication.

"He's our president and I would rather he not be taking something that has not been approved by the scientists, especially in his age group and in his, shall we say, weight group - morbidly obese, they say," she said.

Last year, the White House physician noted in Mr Trump's annual medical exam that he weighed 243lb (110kg) and was 6ft 3in, which would score his body mass index at a technically obese 30.4.

Senate Democratic Minority Leader Chuck Schumer called Mr Trump's decision "reckless" but added: "Who knows if it's true?"

"He may not have been taking it for all we know. He just likes to make a splash," he told MSNBC.

"Maybe he's really not taking it," he continued, "because the president lies about things characteristically-like."

Is Trump misguided or a trailblazer?
Analysis by Michelle Roberts, Health Editor

I'll have what President Trump's having. No thanks - or rather, not yet.

Currently there is no convincing evidence that hydroxychloroquine helps fight the virus and it can cause unpleasant and harmful side effects in some people.

In theory, repurposing existing drugs to treat coronavirus is a very good and sound idea (unlike Mr Trump's previous ones about injecting disinfectant or hitting the body with "tremendous" UV light). It may be our only hope, at least in the short term, until a vaccine can be found.

The UK government has been stockpiling some medicines that might be useful against coronavirus. That includes 16m hydroxychloroquine tablets. Clinical trials are under way in the UK and the US to assess the drug's worth. The human guinea pigs taking part include frontline healthcare workers at high risk of exposure to the virus, as well as patients.

Experts agree that this work is worth doing, but they are concerned about advocating more general use of these experimental treatments before the proof is in.

Dr Stephen Griffin, associate professor at the School of Medicine at the University of Leeds, told me: "People that follow the president's example might not only endanger themselves but could also deprive patients with chronic autoimmune conditions of their much-needed medication."

(Source: BBC)

Tuesday, 21 April 2020

Coronavirus: Plasma treatment to be trialled

The UK is gearing up to use the blood of coronavirus survivors to treat hospital patients ill with the disease.

NHS Blood and Transplant is asking some people who recovered from Covid-19 to donate blood so they can potentially assess the therapy in trials.

The hope is that the antibodies they have built up will help to clear the virus in others.

The US has already started a major project to study this, involving more than 1,500 hospitals.

When a person has Covid-19, their immune system responds by creating antibodies, which attack the virus.
PA
Over time these build up and can be found in the plasma, the liquid portion of the blood.

NHSBT is now approaching patients who have recovered from Covid-19 to see if plasma from them can be given to people who are currently ill with the virus.

A statement from the organisation said: "We envisage that this will be initially used in trials as a possible treatment for Covid-19.

"If fully approved, the trials will investigate whether convalescent plasma transfusions could improve a Covid-19 patient's speed of recovery and chances of survival.

"All clinical trials have to follow a rigorous approval process to protect patients and to ensure robust results are generated. We are working closely with the government and all relevant bodies to move through the approvals process as quickly as possible."

Are other groups doing this?
Several groups in the UK have been looking into using blood plasma.
University Hospital of Wales (UHW) in Cardiff announced this week that it wanted to trial the technology.

Professor Sir Robert Lechler, president of the Academy of Medical Sciences and executive director of King's Health Partners, which includes King's College London and three major London hospitals, is also hoping to set up another small-scale trial.

He wants to use plasma for seriously ill patients that have no other treatment options, while a larger national trial is getting under way.

He said: "I would be disappointed if we weren't able to see some patients given this form of therapy within a couple of weeks. Let's hope that the NHSBT national trial gets into gear really quickly."

He said the UK had moved slowly to test the treatment.

"I think there are many aspects of this pandemic we'll look back on and say, I wonder why we didn't move a little bit faster. I think this could be one of those".

What is the situation in the rest of the world?
Around the world, trials are now under way to look at using plasma.

In just three weeks, scientists in the US have organised a nationwide project and about 600 patients have been treated so far.

Prof Michael Joyner, from the Mayo Clinic, is leading the work.

He said: "The thing we've learned in the first week of administration is that no major safety signals have emerged and administration of the product does not appear to be causing a whole lot of unanticipated side effects.

"There are anecdotal reports of oxygenation improving and other patient improvements. Those are certainly heartening, but they need to be rigorously evaluated."

He said the therapy was "rough and ready".

"There's a lot we don't understand about the plasma. We're going to learn more about what's in the plasma, the components, the antibody levels, and other factors that may be there as the weeks go on.

"But sometimes, as a physician, you just have to try to take a shot on goal when you have a shot."
Getty Images

How has this approach helped in previous pandemics?
Harnessing the blood of recovered patients is not a new idea in medicine. It was used more than 100 years ago during the Spanish Flu epidemic, and more recently for Ebola and Sars.

So far, only small studies have looked at its efficacy, and there is a great deal of research that needs to be done to see how effective it will be against coronavirus.

But in the US, they say they have no shortage of people who want to help.

Bruce Sachais, chief medical officer at the New York Blood Center, said: "People have been amazing. They keep coming out in droves.

"We have hundreds and hundreds of donors and we've been able to collect over 1,000 units already. It's really heart-warming to see that for people who have gone through the infection, in various degrees, their main concern is 'how can I now help others?'"

Scientists say plasma won't be a magic bullet.

But while our options for treating coronavirus are so limited, the hope is it could help until a vaccine is found.

(Source: BBC)

Fears China is facing second wave of coronavirus as infections are reported among staff at hospital in Henan after medic returned from Wuhan - while official figures put new cases at just 16

A reported new coronavirus outbreak in China's Henan province is said to have raised fears that there could be devastating second wave of the deadly virus.

A new cluster of cases has allegedly broken out among medical staff at Jia County's People's Hospital in the region.

One staff member is said to have only just come back from 14 days in quarantine after they returned from Wuhan in neighbouring Hubei province, where the virus first emerged at the end of last year. 

News of the alleged new outbreak, which was reported by the Daily Express, came as China reported 16 new confirmed coronavirus cases on April 18, the lowest since March 17 and down from 27 a day earlier.

It means the total number of confirmed coronavirus cases in the mainland reached 82,735 as of April 18, while the total death toll from the virus stood at 4,632. 
A reported new coronavirus outbreak in China's Henan province is said to have raised fears that there could be a devastating second wave of the deadly virus. Pictured: Security guards lock the gate of the Forbidden City in Beijing on Sunday. AP
The claimed new COVID-19 outbreak has prompted authorities to impose travel restrictions. 

Anyone coming in or out of residential compounds also needs to wear a facemask and have their temperature taken, according to an official document leaked to Radio Free Asia. 

The Express also reported that businesses in Jia County are also closed except for supermarkets and farmers' markets. 

The paper quoted residents who opened up on Weibo, the country's approved social media service, about what life is like. 

One resident said: 'Everything's locked down. It just started.

'All households are locked down. Nobody can go into town, or if you do, you won't be able to leave again.' 

Another resident said: 'Many people believe that the epidemic has been brought under control due to government propaganda, which is false.     

The news comes as authorities remain on guard against a major resurgence of he virus, which could be socially and economically destabilising.

Notably, the northeastern province of Heilongjiang has seen a surge in infected travellers arriving from Russia in recent weeks, and is now battling to contain a flare-up in local cases.

The data from China's National Health Commission showed nine of the new cases reported on Saturday were imported infections, the lowest since March 13 and down from 17 a day earlier. 

The remaining seven confirmed cases were locally transmitted, down from 10 the previous day. 

Heilongjiang, in north-east China, has reported 39 new local cases in the past 10 days, or more than 50 per cent of all the new 73 local cases reported in the mainland during the same period.

Most of the cases were related to one imported case in the provincial capital Harbin.

On Friday, a total of 18 officials in Harbin, including a vice mayor, were punished.
A new cluster of cases has allegedly broken out among medical staff at Jia County's People's Hospital in the region. Pictured: medical staff at a hospital in Wuhan disinfect surfaces. Xinhua/Rex
To contain the outbreak quickly, the Heilongjiang government is cautioning against family gatherings, cross infections at hospitals, and slow reporting in epidemic investigations, according to a statement on the provincial government website.

'The biggest political task at present is to stop the rebound and spread of the epidemic,' Wang Yongkang, vice governor of Heilongjiang, was quoted as saying.

Elsewhere in mainland China, all areas in central Hubei province including Wuhan, the epicentre of the outbreak in China, are now considered low-risk.

However, a Beijing central district is seen as high-risk, according to a social media post by the State Council, or Cabinet.

On April 15, the Chinese capital reported three local cases, all of which were linked to an imported infection.

Areas that are considered of medium-risk in China include two districts in Harbin, the city of Suifenhe in Heilongjiang, two districts in the southern city of Guangzhou as well as Jiaozhou city in eastern Shandong province.

In mainland China, newly discovered asymptomatic cases stood at 44, down from 54 a day earlier. Three of the new cases were imported, according to the health commission.

China does not include asymptomatic cases, or patients who test positive but show no clinical symptoms such as a cough or fever, in its tally of confirmed cases.

The new figures came as a laboratory in Wuhan rejected as 'impossible' US theories that it is the cradle of the pandemic, as President Donald Trump warned Beijing of consequences if it was 'knowingly responsible'. 

'Was it a mistake that got out of control or was it done deliberately?' 
News of the alleged new outbreak, which was reported by the Daily Express, came as China reported 16 new confirmed coronavirus cases on April 18, the lowest since March 17 and down from 27 a day earlier

Trump said at a White House briefing Saturday, questioning the origins of the disease, which first emerged in the city of Wuhan in December.

'If they were knowingly responsible, yeah, then there should be consequences,' he said when asked if China should face repercussions for the pandemic.

The highly contagious disease was likely first transmitted to humans at a market where exotic animals were slaughtered, according to Chinese scientists.

But conspiracy theories that the virus came from a maximum-security virology lab have been brought into the mainstream in recent days by US government officials.

Secretary of State Mike Pompeo said an investigation was underway into how the virus 'got out into the world'.

'There's no way this virus came from us,' Yuan Zhiming, the head of the P4 laboratory at the Wuhan Institute of Virology, which is equipped to handle dangerous viruses, said in an interview with state media.

'I know it's impossible,' he added.

(Source: Daily Mail)

Saturday, 11 April 2020

India to send 1.4 crore hydroxychloroquine tablets to 13 countries

India has cleared first list of 13 countries for sending Hydroxychloroquine. The name of the countries in the first list are USA, Spain, Germany, Bahrain, Brazil, Nepal, Bhutan, Afghanistan, Maldives, Bangladesh, Seychelles, Mauritius & Dominican Republic.


USA had asked for 48 lakh tablets of HCQ, India has sanctioned 35.82 lakh tablets.

Germany will also get 50 lakh tablets of Hydroxychloroquine in the second consignment.

Brazil will get 50 lakh tablets of Hydroxychloroquine in the second consignment.

Canada will get 50 lakh tablets of Hydroxychloroquine (in second consignment); in first consignment they are only receiving 1.5 MT API.

Bangladesh will get 20 lakh tablets of Hydroxychloroquine.

Nepal will get 10 lakh tablets of Hydroxychloroquine.

Bhutan will get 2 lakh tablets of Hydroxychloroquine.

Sri Lanka will get 10 lakh tablets of Hydroxychloroquine in the second consignment.

Afghanistan will get 5 lakh tablets of Hydroxychloroquine.

Maldives will get 2 lakh tablets of Hydroxychloroquine.

According to Health ministry, India needs one crore Hydroxychloroquine tablets, and currently India has 3.28 crore Hydroxychloroquine tablets and 1-2 crore tablets can be produced.

Wednesday, 8 April 2020

Hydroxychloroquine: India agrees to release drug after Trump retaliation threat

India has agreed to lift an export ban on a drug US President Donald Trump has called a "game-changer" in the fight against coronavirus, despite reservations from medical experts.

The decision came after Mr Trump warned of "retaliation" if India did not drop the ban on hydroxychloroquine exports.

The president has repeatedly touted the drug as a possible cure for Covid-19, despite a lack of proof.
India is one of the world's largest manufacturers of hydroxychloroquine.

It is unclear how much will now be exported. Anurag Srivastava, spokesperson for the Ministry of External Affairs, said on Tuesday that the "the stock position could allow our companies to meet the export commitments that they had contracted".

What happened between the US and India?
President Trump - who, according to the New York Times, owns a "small personal financial interest in Sanofi, the French drugmaker that makes... the brand-name version of hydroxychloroquine" - called Indian Prime Minister Narendra Modi on Sunday, a day after India banned all exports of the drug "without exception".

The decision came even as Indian cases spiked - as of Tuesday, the country reported 3,981 active cases and 114 deaths due to the virus.

The next day, local media reported that India would "consider" the request.

The same day, speaking at a White House press briefing, Mr Trump said he did not "like" India's decision to ban the export of the drug. "But of course, there may be retaliation," he said. "Why wouldn't there be?"

India's statement on Tuesday also said that apart from "nations badly affected by the virus" it would supply the drug to neighbouring countries in "appropriate quantities" given the "humanitarian aspects of the pandemic".

The US has recorded nearly 370,000 virus cases and almost 11,000 deaths.

What is hydroxychloroquine?
Hydroxychloroquine is very similar to chloroquine, one of the oldest and best-known anti-malarial drugs.

But the drug - which can also treat auto-immune diseases like rheumatoid arthritis and lupus - has also attracted attention over the past few decades as a potential antiviral agent.

President Trump said that the US Food and Drug Administration (FDA) had approved it for treating coronavirus, something the organization has denied. Mr Trump later said that it had been approved for "compassionate use" - which means a doctor can give a drug that is yet to be cleared by the government to a patient in a life-threatening condition.

Doctors are able to prescribe chloroquine in these circumstances as it's a registered drug.

In India, hydroxychloroquine could be bought over the counter and is fairly inexpensive, but its purchase and use has been severely restricted ever since it was named as a possible treatment for Covid-19.


Does it work against Covid-19?
"Chloroquine seems to block the coronavirus in lab studies. There's some anecdotal evidence from doctors saying it has appeared to help," James Gallagher, BBC health correspondent, explained.

But crucially, there have been no complete clinical trials, which are important to show how the drug behaves in actual patients, although they are under way in China, the US, UK and Spain.

"If it truly has a dramatic effect on the clinical course of Covid-19 we would already have evidence for that. We don't, which tells us that hydroxychloroquine, if it even works at all, will likely be shown to have modest effects at best," Dr Joyeeta Basu, a senior consultant physician in India, told the BBC.

Despite the fact trials are yet to conclude, people have begun to self-medicate - with sometimes disastrous consequences.

There have been numerous reports in Nigeria of people being poisoned from overdoses after people were reportedly inspired by Mr Trump's enthusiastic endorsement of the drug.

An article in the Lancet medical journal also warns hydroxychloroquine can have dangerous side-effects if the dose is not carefully controlled.

This lack of certainty has prompted social media sites like Facebook and Twitter to delete posts that tout it as a cure - even when they are made by world leaders.


(Source: BBC)

Monday, 23 March 2020

Nigeria records chloroquine poisoning after Trump endorses it for coronavirus treatment

Health officials in Nigeria have issued a warning over chloroquine after they said three people in the country overdosed on the drug, in the wake of President Trump's comments about using it to treat coronavirus.

A Lagos state official told CNN that three people were hospitalized in the city after taking the drug. Officials later issued a statement cautioning against using chloroquine for Covid-19 treatment.
US President Donald Trump claimed at a White House briefing last week that the Food and Drug Administration had approved the "very powerful" drug chloroquine to treat coronavirus.

"It's shown very encouraging -- very, very encouraging early results. And we're going to be able to make that drug available almost immediately. And that's where the FDA has been so great. They -- they've gone through the approval process; it's been approved. And they did it -- they took it down from many, many months to immediate. So we're going to be able to make that drug available by prescription or states," Trump said.

He added: "Normally the FDA would take a long time to approve something like that, and it's -- it was approved very, very quickly and it's now approved, by prescription."

However, the FDA after the briefing issued a statement saying it had not approved the drug for use against Covid-19 and is still studying its effectiveness against the disease.

Price hikes
Trump's endorsement of the drug led to a surge of interest among Nigerians keen to stock up on the medication, which has led to inevitable price hikes in the megacity of around 20 million inhabitants.

One man told CNN that in a pharmacy near his home on the Lagos mainland, he witnessed the price rise by more than 400% in a matter of minutes.

Kayode Fabunmi, a Lagos-based lawyer, said: "The pharmacist knew the market and was saying to every incoming customer, 'You know Donald Trump has said this thing cures coronavirus,' and the price kept changing.

"The original price was 200 naira (around 50 cents), then it became 500 naira ($1.38) then it became 1,000 naira ($2.77) while I was there," he said.

The Lagos State Health Ministry issued a brief statement saying there was no "hard evidence that chloroquine is effective in prevention or management of coronavirus infection."

Chloroquine is used to treat malaria, lupus and rheumatoid arthritis.

Malaria is an endemic disease in Nigeria and other parts of Africa and for many years, it was common to treat it with chloroquine. However, at least 40 African countries, including Nigeria, have phased it out as a frontline antimalarial drug and replaced it with other drugs following widespread resistance to it.

Lack of clinical evidence
While doctors in China, the United States and other countries have used the drug experimentally in Covid-19 patients, there is not yet enough clinical evidence that it's effective in humans or the management of the disease.

Dr. Michel Yao, Africa emergency response program manager for the World Health Organization, told CNN there are 20 drugs and the same number of vaccines under clinical trial, and it is too early to make recommendations about the efficacy of any for the treatment of the virus.

"The WHO's position is clear. Any medication should be based on evidence. We don't have yet any evidence from any of these trials that would allow WHO to do a formal recommendation. All these are in progress, so it is difficult for us to recommend at this stage that any of the medicine can be of use for the treatment of coronavirus," Yao said.

"It is too early to rush to the decision that chloroquine ... at least for WHO to recommend it for the treatment of coronavirus," he added.

Side effects
Fabunmi, 44, told CNN he had used chloroquine before to treat malaria and recalled that severe itching was one of the side effects.

"For two, three days you will be itching," he said. "You dread having a bath, you will scratch and scratch and you would have to take piriton (an antihistamine) alongside it.

"It's also very bitter. If you make the mistake of letting it drop in your mouth, you will feel the taste for a long time."
Nigeria as of Sunday has reported 30 cases of Covid-19 and Fabunmi said he feels better having his batch of chloroquine.

"I didn't mind paying as I just wanted to get some in case it will become necessary. ... I didn't want a situation where I will regret not buying it. Better to be safe than sorry," he said.

(Source: CNN)